Velasquez WS - Search Results

1

Multivariate analysis of prognostic factors in stage IV follicular low-grade lymphoma: a risk model.

Romaguera JE, McLaughlin P, North L, Dixon D, Silvermintz KB, Garnsey LA, Velasquez WS, Hagemeister FB, Cabanillas F. Romaguera JE, et al. Among authors: velasquez ws. J Clin Oncol. 1991 May;9(5):762-9. doi: 10.1200/JCO.1991.9.5.762. J Clin Oncol. 1991. PMID: 1707956

2

Phase II trial of fludarabine phosphate in lymphoma: an effective new agent in low-grade lymphoma.

Redman JR, Cabanillas F, Velasquez WS, McLaughlin P, Hagemeister FB, Swan F Jr, Rodriguez MA, Plunkett WK, Keating MJ. Redman JR, et al. Among authors: velasquez ws. J Clin Oncol. 1992 May;10(5):790-4. doi: 10.1200/JCO.1992.10.5.790. J Clin Oncol. 1992. PMID: 1373760 Clinical Trial.

3

Therapy of relapsed or refractory low-grade follicular lymphomas: factors associated with complete remission, survival and time to treatment failure.

Spinolo JA, Cabanillas F, Dixon DO, Khorana SM, McLaughlin P, Velasquez WS, Hagemeister FB, Redman JR, Swan F Jr. Spinolo JA, et al. Among authors: velasquez ws. Ann Oncol. 1992 Mar;3(3):227-32. doi: 10.1093/oxfordjournals.annonc.a058157. Ann Oncol. 1992. PMID: 1586621 Free article.

4

Stomach conservation in stages IE and IIE gastric non-Hodgkin's lymphoma.

Maor MH, Velasquez WS, Fuller LM, Silvermintz KB. Maor MH, et al. Among authors: velasquez ws. J Clin Oncol. 1990 Feb;8(2):266-71. doi: 10.1200/JCO.1990.8.2.266. J Clin Oncol. 1990. PMID: 1688927

5

Stages I and II diffuse large cell lymphomas: prognostic factors and long-term results with CHOP-bleo and radiotherapy.

Velasquez WS, Fuller LM, Jagannath S, Tucker SL, North LB, Hagemeister FB, McLaughlin P, Swan F, Redman JR, Rodriguez MA, et al. Velasquez WS, et al. Blood. 1991 Mar 1;77(5):942-7. Blood. 1991. PMID: 1704805 Free article.

6

Clinical, biologic, and histologic features of late relapses in diffuse large cell lymphoma.

Cabanillas F, Velasquez WS, Hagemeister FB, McLaughlin P, Redman JR. Cabanillas F, et al. Among authors: velasquez ws. Blood. 1992 Feb 15;79(4):1024-8. Blood. 1992. PMID: 1737086 Free article.

7

Discordant bone marrow involvement in diffuse large-cell lymphoma: a distinct clinical-pathologic entity associated with a continuous risk of relapse.

Robertson LE, Redman JR, Butler JJ, Osborne BM, Velasquez WS, McLaughlin P, Swan F, Rodriguez MA, Hagemeister FB, Fuller LM, et al. Robertson LE, et al. Among authors: velasquez ws. J Clin Oncol. 1991 Feb;9(2):236-42. doi: 10.1200/JCO.1991.9.2.236. J Clin Oncol. 1991. PMID: 1988571

8

Two cycles of MOPP and radiotherapy: effective treatment for stage IIIA and IIIB Hodgkin's disease.

Hagemeister FB, Fuller LM, Velasquez WS, McLaughlin P, Redman JR, Swan F, Rodriguez MA, North L, Dixon D, Silvermintz K, et al. Hagemeister FB, et al. Among authors: velasquez ws. Ann Oncol. 1991 Jan;2(1):25-31. doi: 10.1093/oxfordjournals.annonc.a057819. Ann Oncol. 1991. PMID: 2009233 Free article.

9

Prognostic value of serum beta-2 microglobulin in low-grade lymphoma.

Litam P, Swan F, Cabanillas F, Tucker SL, McLaughlin P, Hagemeister FB, Rodriguez MA, Velasquez WS. Litam P, et al. Among authors: velasquez ws. Ann Intern Med. 1991 May 15;114(10):855-60. doi: 10.7326/0003-4819-114-10-855. Ann Intern Med. 1991. PMID: 2014946

10

NOVP: a novel chemotherapeutic regimen with minimal toxicity for treatment of Hodgkin's disease.

Hagemeister FB, Cabanillas F, Velásquez WS, Meistrich ML, Liang JC, McLaughlin P, Redman JR, Romaguera JE, Rodríguez MA, Swan F Jr, et al. Hagemeister FB, et al. Among authors: velasquez ws. Semin Oncol. 1990 Dec;17(6 Suppl 10):34-8; discussion 38-40. Semin Oncol. 1990. PMID: 2259922

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

89 results

Search Page

Filters